$724 Million is the total value of Avidity Partners Management LP's 52 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 145.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SGEN | New | SEATTLE GENETICS INC | $66,920,000 | – | 580,000 | +100.0% | 9.25% | – |
| MRK | New | MERCK & CO. INC | $37,854,000 | – | 492,000 | +100.0% | 5.23% | – |
| ABBV | Buy | ABBVIE INC | $36,343,000 | +336.7% | 477,000 | +407.4% | 5.02% | -4.2% |
| MCK | New | MCKESSON CORP | $32,868,000 | – | 243,000 | +100.0% | 4.54% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $25,519,000 | – | 302,000 | +100.0% | 3.53% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $24,415,000 | – | 50,000 | +100.0% | 3.37% | – |
| CAH | New | CARDINAL HEALTH INC | $24,210,000 | – | 505,000 | +100.0% | 3.35% | – |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $22,677,000 | +175.0% | 295,000 | +360.9% | 3.13% | -39.7% |
| CTLT | Buy | CATALENT INC | $21,351,000 | +312.2% | 411,000 | +346.7% | 2.95% | -9.6% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $21,216,000 | +437.7% | 780,000 | +290.0% | 2.93% | +17.9% |
| BIIB | New | BIOGEN INC | $19,616,000 | – | 62,000 | +100.0% | 2.71% | – |
| EXEL | New | EXELIXIS INC | $18,701,000 | – | 1,086,000 | +100.0% | 2.58% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $18,376,000 | – | 540,000 | +100.0% | 2.54% | – |
| ALEC | New | ALECTOR INC | $17,229,000 | – | 714,000 | +100.0% | 2.38% | – |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $17,151,000 | +264.9% | 1,182,000 | +409.5% | 2.37% | -20.0% |
| CVS | New | CVS HEALTH CORP | $16,434,000 | – | 277,000 | +100.0% | 2.27% | – |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $15,083,000 | +552.9% | 357,000 | +561.1% | 2.08% | +43.1% |
| GILD | New | GILEAD SCIENCES INC | $14,952,000 | – | 200,000 | +100.0% | 2.07% | – |
| XLRN | New | ACCELERON PHARMA INC | $14,918,000 | – | 166,000 | +100.0% | 2.06% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $14,366,000 | – | 160,000 | +100.0% | 1.98% | – |
| SGEN | New | SEATTLE GENETICS INCcall | $13,581,000 | – | 117,700 | +100.0% | 1.88% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $13,499,000 | +202.5% | 3,824,000 | +390.3% | 1.87% | -33.6% |
| KDMN | Buy | KADMON HLDGS INC | $11,849,000 | +215.1% | 2,828,000 | +240.7% | 1.64% | -30.9% |
| AXSM | New | AXSOME THERAPEUTICS INC | $11,590,000 | – | 197,000 | +100.0% | 1.60% | – |
| CI | Buy | CIGNA CORP NEW | $11,517,000 | +87.7% | 65,000 | +116.7% | 1.59% | -58.8% |
| QURE | Buy | UNIQURE NV | $11,246,000 | +185.4% | 237,000 | +330.9% | 1.55% | -37.4% |
| MRNA | New | MODERNA INC | $10,932,000 | – | 365,000 | +100.0% | 1.51% | – |
| HUM | New | HUMANA INC | $10,363,000 | – | 33,000 | +100.0% | 1.43% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $9,863,000 | +81.6% | 333,000 | +122.0% | 1.36% | -60.2% |
| CCXI | New | CHEMOCENTRYX INC | $9,482,000 | – | 236,000 | +100.0% | 1.31% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,482,000 | +139.1% | 98,000 | +197.0% | 1.17% | -47.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $8,090,000 | -7.6% | 34,000 | -15.0% | 1.12% | -79.7% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $7,826,000 | – | 80,000 | +100.0% | 1.08% | – |
| LGND | New | LIGAND PHARMACEUTICALS INC | $7,417,000 | – | 102,000 | +100.0% | 1.02% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $7,416,000 | – | 735,000 | +100.0% | 1.02% | – |
| VSTM | New | VERASTEM INC | $7,367,000 | – | 2,790,698 | +100.0% | 1.02% | – |
| CRL | New | CHARLES RIV LABS INTL INC | $7,194,000 | – | 57,000 | +100.0% | 0.99% | – |
| AGN | New | ALLERGAN PLC | $7,084,000 | – | 40,000 | +100.0% | 0.98% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $6,845,000 | – | 507,000 | +100.0% | 0.95% | – |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $6,757,000 | +15.4% | 60,000 | +42.5% | 0.93% | -74.7% |
| IMMU | Buy | IMMUNOMEDICS INC | $6,646,000 | +124.4% | 493,000 | +252.1% | 0.92% | -50.8% |
| AMRN | New | AMARIN CORP PLCcall | $6,499,000 | – | 1,624,800 | +100.0% | 0.90% | – |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $6,464,000 | -16.9% | 205,000 | +57.2% | 0.89% | -81.8% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $6,196,000 | +60.4% | 382,000 | +78.1% | 0.86% | -64.8% |
| NERV | New | MINERVA NEUROSCIENCES INCcall | $5,960,000 | – | 990,000 | +100.0% | 0.82% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $5,883,000 | – | 408,000 | +100.0% | 0.81% | – |
| ANIK | New | ANIKA THERAPEUTICS INC | $4,857,000 | – | 168,000 | +100.0% | 0.67% | – |
| BTAI | New | BIOXCEL THERAPEUTICS INC | $4,716,000 | – | 211,000 | +100.0% | 0.65% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,033,000 | – | 382,000 | +100.0% | 0.42% | – |
| NERV | New | MINERVA NEUROSCIENCES INC | $2,674,000 | – | 444,200 | +100.0% | 0.37% | – |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $1,788,000 | +278.0% | 4,310,000 | +207.9% | 0.25% | -17.1% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $278,000 | -92.5% | 17,000 | -90.6% | 0.04% | -98.4% |
| Buy | -- | $0 | – | 0 | +100.0% | 0.00% | – | |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -10,000 | -100.0% | -0.25% | – |
| ARAV | Exit | ARAVIVE INC | $0 | – | -30,000 | -100.0% | -0.26% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -0.43% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -15,000 | -100.0% | -0.86% | – |
| NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -210,000 | -100.0% | -1.63% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -31,000 | -100.0% | -1.81% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -19,000 | -100.0% | -2.62% | – |
| ABEO | Exit | ABEONA THERAPEUTICS INC | $0 | – | -1,325,000 | -100.0% | -2.73% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -93,000 | -100.0% | -3.30% | – |
| AXNX | Exit | AXONICS MODULATION TECH INC | $0 | – | -208,000 | -100.0% | -3.63% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -27,000 | -100.0% | -3.97% | – |
| ZBH | Exit | ZIMMER BIOMET HLDGS INC | $0 | – | -54,500 | -100.0% | -5.14% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -62,700 | -100.0% | -5.84% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -165,000 | -100.0% | -8.69% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.